Atrium Therapeutics, Inc. Common Stock share price logo

Atrium Therapeutics, Inc. Common Stock

NASDAQ: RNA

Small Cap

$13.08

-0.01

(-0.08%)

Live

as on

Atrium Therapeutics, Inc. Common Stock Stock Performance

as on May 8, 2026 at 1:10 am IST

  • Day's Low

    Day's High

    $12.96
    $13.20
    downward going graph

    0.92%

    Downside

    0.92%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.95
    $73.06
    downward going graph

    8.64%

    Downside

    458.56%

    Upside

    downward going graph

Atrium Therapeutics, Inc. Common Stock share price movements today

Previous Close
$13.09
Open
$13.07
Volume
19.3K
Day's Low - High
$12.96 - $13.20
52 Week Low - High
$11.95 - $73.06

Atrium Therapeutics, Inc. Common Stock Historical Returns

1 Month Return
-6.43 %
3 Month Return
-82.04 %
1 Year Return
-49.98 %
3 Year Return
+ 13.04 %
5 Year Return
0 %

Atrium Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Atrium Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$200.3M

EPS (TTM)

-4.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-49.3M

Revenue (TTM)

18.6M

Profit Margin

-265.88%

Return On Equity TTM

-43.98%

Atrium Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atrium Therapeutics, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$200.3MNANA-265.88%
BUY$40.5B130.77%76.3212.55%
BUY$108.5B98.9%25.3835.51%
NA$32.5BNA70.895.37%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Atrium Therapeutics, Inc. Common Stock Stock including INR - Dollar returns

The Atrium Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Atrium Therapeutics, Inc. Common Stock investment value today

Current value as on today

₹55,596

Returns

-₹44,404

(-44.4%)

Returns from Atrium Therapeutics, Inc. Common Stock Stock

-₹50,019 (-50.02%)

Dollar Impact

₹5,615 (+5.62%)

Analyst Recommendation on Atrium Therapeutics, Inc. Common Stock Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Atrium Therapeutics, Inc. Common Stock. Average target price of $25

Atrium Therapeutics, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Atrium Therapeutics, Inc. Common Stock.

What analysts predicted

47.68%UPSIDE

Target Price

$25

Current Price

$13.08

Analyzed by

12 Analysts

Target

$25.00

Atrium Therapeutics, Inc. Common Stock target price $25, a slight upside of 47.68% compared to current price of $13.08. According to 12 analysts rating.

Indian Investors' Interest in Atrium Therapeutics, Inc. Common Stock Stock

Search interest for Atrium Therapeutics, Inc. Common Stock Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Atrium Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
2
3
2
2
2
1
3
12
0
Gross Profit
-44
1
2
1
2
2
1
-134
12
0
Operating Income
-58
-66
-77
-82
-98
-120
-131
-171
-188
-48
EBITDA
-58
-66
-76
-81
-97
-120
-130
-170
-173
-47
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
1
0
Income Before Tax
-52
-60
-68
-70
-80
-102
-115
-157
-174
-48
Income Tax Expense
-6
0
0
-
-
-
-
-
-
0
Net Income
-52
-60
-68
-70
-80
-102
-115
-157
-174
-29
Net Profit Margin
-1857.98%
-2756.18%
-1943.41%
-3461.76%
-3441.70%
-3439.52%
-7360.01%
-4089.29%
-1398.33%
-3391.85%

Atrium Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
2
6
9
9
9
10
18
Gross Profit
-8
2
6
9
9
7
10
18
Operating Income
-10
-17
-44
-118
-178
-235
-378
-76
EBITDA
-10
-16
-43
-117
-177
-233
-376
-76
Interest Expense
0
7
0
0
5
-
-
-
Depreciation
0
0
0
0
1
1
2
0
Income Before Tax
-11
-24
-44
-118
-173
-212
-322
-76
Income Tax Expense
0
7
0
0
-4
1
-
0
Net Income
-11
-24
-43
-117
-169
-212
-322
-76
Net Profit Margin
-3148.81%
-1066.58%
-648.03%
-1258.52%
-1833.01%
-2219.87%
-2957.71%
-411.88%

Atrium Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-60
-68
-70
-80
-102
-115
-157
-174
-29
Operating Cash Flow
16
-70
-65
-65
-99
-124
-199
-156
-19
Investing Cash Flow
51
-32
-274
-482
-64
157
185
-587
0
Financing Cash Flow
31
389
446
342
13
1
3
850
20
Change in Cash
99
286
106
-205
-150
34
-10
106
32

Atrium Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2013
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-
-11
-24
-44
-118
-173
-212
-322
-49
Operating Cash Flow
-
-9
2
-37
-94
-136
-119
-300
-41
Investing Cash Flow
-
0
0
-7
-82
-189
-130
-854
-1
Financing Cash Flow
88
5
89
272
176
346
93
1,192
42
Change in Cash
-
-4
91
227
-1
19
-155
37
162

Global Institutional Holdings in Atrium Therapeutics, Inc. Common Stock

Funds
Holdings
venBio Select Advisor LLC
4.93%
Geode Capital Management, LLC
1.84%
The Goldman Sachs Group Inc
2.43%
Bellevue Group AG
1.7%
Millennium Management LLC
1.39%

Atrium Therapeutics, Inc. Common Stock News & Key Events

    Insights on Atrium Therapeutics, Inc. Common Stock

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -174.44M → -29.13M (in $), with an average increase of 498.7% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 12.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, BeOne Medicines Ltd has given 34.9% return, outperforming this stock by 84.9%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 12.47M → 859.0K (in $), with an average decrease of 93.1% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 3 months, RNA stock has moved down by -82.0%

    About Atrium Therapeutics, Inc. Common Stock

    Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.
    OrganisationAtrium Therapeutics, Inc. Common Stock
    Headquarters10578 Science Center Drive, San Diego, CA, United States, 92121
    IndustryBiotechnology
    CEOMs. Kathleen P. Gallagher
    E-voting on sharesClick here to vote

    Key Management of Atrium Therapeutics, Inc. Common Stock

    Name

    Title

    Ms. Rocio Martin Hoyos

    Chief Strategy Officer

    Ms. Kathleen P. Gallagher

    President, CEO & Director

    Mr. Brendan Winslow

    Chief Financial Officer

    Dr. Husam Younis

    Chief Scientific Officer

    Ms. Stephanie Kenney

    Chief Corporate Affairs Officer

    Dr. Steven George Hughes M.B.A., M.D.

    Chief Medical Officer

    FAQs

    What is Atrium Therapeutics, Inc. Common Stock share price today?

    Atrium Therapeutics, Inc. Common Stock share price today is $13.08 as on . Atrium Therapeutics, Inc. Common Stock share today touched a day high of $13.2 and a low of $12.96.

    What is the 52 week high and 52 week low for Atrium Therapeutics, Inc. Common Stock share?

    Atrium Therapeutics, Inc. Common Stock share touched a 52 week high of $73.06 on and a 52 week low of $11.95 on . Atrium Therapeutics, Inc. Common Stock stock price today i.e. is trending at $13.08,which is 82.10% down from its 52 week high and 9.46% up from its 52 week low.

    What is Atrium Therapeutics, Inc. Common Stock's market capitalisation today?

    Atrium Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on .

    How to invest in Atrium Therapeutics, Inc. Common Stock Stock (RNA) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Atrium Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atrium Therapeutics, Inc. Common Stock Shares that will get you 0.1147 shares as per Atrium Therapeutics, Inc. Common Stock share price of $13.08 per share as on May 7, 2026 at 7:40 pm IST.

    What is the minimum amount required to buy Atrium Therapeutics, Inc. Common Stock Stock (RNA) from India?

    Indian investors can start investing in Atrium Therapeutics, Inc. Common Stock (RNA) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹942.40 in Atrium Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Atrium Therapeutics, Inc. Common Stock share’s latest price of $13.08 as on May 7, 2026 at 7:40 pm IST, you will get 0.7645 shares of Atrium Therapeutics, Inc. Common Stock. Learn more about fractional shares .